newsfilter
← Latest News
PR Newswire·

Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

RED BANK, N.J., Feb. 23, 2023 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today